Globus Medical ROA 2010-2018 | GMED
Current and historical return on assets (ROA) values for Globus Medical (GMED) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Globus Medical ROA for the three months ending September 30, 2018 was 14.02%.
| Globus Medical ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2018-09-30 | $0.14B | $1.24B | 12.41% |
| 2018-06-30 | $0.14B | $1.19B | 12.17% |
| 2018-03-31 | $0.12B | $1.13B | 11.23% |
| 2017-12-31 | $0.11B | $1.08B | 10.61% |
| 2017-09-30 | $0.11B | $1.04B | 11.02% |
| 2017-06-30 | $0.11B | $1.00B | 11.41% |
| 2017-03-31 | $0.11B | $0.96B | 11.48% |
| 2016-12-31 | $0.10B | $0.93B | 11.75% |
| 2016-09-30 | $0.12B | $0.90B | 13.70% |
| 2016-06-30 | $0.12B | $0.87B | 14.11% |
| 2016-03-31 | $0.12B | $0.84B | 14.32% |
| 2015-12-31 | $0.11B | $0.83B | 14.38% |
| 2015-09-30 | $0.10B | $0.80B | 13.67% |
| 2015-06-30 | $0.10B | $0.77B | 13.99% |
| 2015-03-31 | $0.10B | $0.74B | 14.31% |
| 2014-12-31 | $0.09B | $0.70B | 14.49% |
| 2014-09-30 | $0.09B | $0.65B | 14.16% |
| 2014-06-30 | $0.08B | $0.62B | 14.38% |
| 2014-03-31 | $0.07B | $0.60B | 12.61% |
| 2013-12-31 | $0.07B | $0.57B | 13.18% |
| 2013-09-30 | $0.07B | $0.53B | 13.99% |
| 2013-06-30 | $0.06B | $0.50B | 13.95% |
| 2013-03-31 | $0.08B | $0.47B | 17.84% |
| 2012-12-31 | $0.07B | $0.45B | 18.68% |
| 2012-09-30 | $0.07B | $0.42B | 18.27% |
| 2012-06-30 | $0.07B | $0.37B | 25.88% |
| 2012-03-31 | $0.06B | $0.36B | 36.26% |
| 2011-12-31 | $0.06B | $0.33B | 68.09% |
| 2011-09-30 | $0.04B | $0.00B | 62.92% |
| 2011-06-30 | $0.03B | $0.00B | 37.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.097B | $0.636B |
| Globus Medical, Inc. is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders. The Company's products fall into one of two categories: innovative fusion or disruptive technologies. Its innovative fusion products address a broad range of spinal fusion surgical procedures. Its disruptive technology products include minimally invasive surgical, motion preservation and advanced biomaterials technologies. Globus Medical, Inc. is based in Audubon, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $97.045B | 22.61 |
| Intuitive Surgical (ISRG) | United States | $59.217B | 58.26 |
| Edwards Lifesciences (EW) | United States | $32.551B | 34.83 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $24.608B | 16.66 |
| IDEXX Laboratories (IDXX) | United States | $17.365B | 49.60 |
| ABIOMED (ABMD) | United States | $14.403B | 103.49 |
| DexCom (DXCM) | United States | $12.274B | 0.00 |
| Teleflex (TFX) | United States | $12.055B | 27.37 |
| Hologic (HOLX) | United States | $11.459B | 18.80 |
| Varian Medical Systems (VAR) | United States | $10.872B | 26.93 |
| STERIS (STE) | United Kingdom | $10.002B | 26.54 |
| LivaNova (LIVN) | United Kingdom | $6.106B | 39.19 |
| Masimo (MASI) | United States | $5.811B | 37.68 |
| Penumbra (PEN) | United States | $4.712B | 284.52 |
| Integra LifeSciences Holdings (IART) | United States | $4.624B | 22.52 |
| Wright Medical Group (WMGI) | Netherlands | $3.695B | 0.00 |
| Cantel Medical (CMD) | United States | $3.586B | 36.13 |
| Inogen (INGN) | United States | $3.026B | 65.32 |
| Integer Holdings (ITGR) | United States | $2.776B | 23.23 |
| Halyard Health (AVNS) | United States | $2.304B | 20.76 |
| Glaukos (GKOS) | United States | $2.142B | 0.00 |
| OPKO Health (OPK) | United States | $1.993B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.921B | 0.00 |
| Mazor Robotics (MZOR) | Israel | $1.535B | 0.00 |
| AxoGen (AXGN) | United States | $1.225B | 0.00 |
| Nevro (NVRO) | United States | $1.217B | 0.00 |
| Luminex (LMNX) | United States | $1.204B | 43.56 |
| Natus Medical (BABY) | United States | $1.146B | 24.06 |
| Pacific Biosciences Of California (PACB) | United States | $1.123B | 0.00 |
| Orthofix (OFIX) | United States | $1.108B | 32.01 |
| CryoLife (CRY) | United States | $1.094B | 95.93 |
| Tactile Systems Technology (TCMD) | United States | $1.081B | 172.12 |
| Intersect ENT (XENT) | United States | $0.952B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.806B | 28.19 |
| Accelerate Diagnostics (AXDX) | United States | $0.782B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.768B | 45.43 |
| ViewRay (VRAY) | United States | $0.663B | 0.00 |
| Veracyte (VCYT) | United States | $0.562B | 0.00 |
| Sientra (SIEN) | United States | $0.522B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.419B | 0.00 |
| Accuray (ARAY) | United States | $0.408B | 0.00 |
| SI-BONE INC (SIBN) | United States | $0.407B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.374B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.365B | 0.00 |
| Nuvectra (NVTR) | United States | $0.325B | 0.00 |
| Fluidigm (FLDM) | United States | $0.322B | 0.00 |
| Neuronetics (STIM) | United States | $0.318B | 0.00 |
| IRadimed (IRMD) | United States | $0.299B | 78.06 |
| SeaSpine Holdings (SPNE) | United States | $0.285B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.280B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.278B | 43.80 |
| Pulse Biosciences (PLSE) | United States | $0.215B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.204B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.189B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.127B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.123B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.103B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.098B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.094B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.090B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.077B | 0.00 |
| EDAP TMS (EDAP) | France | $0.076B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.072B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.068B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.066B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.046B | 0.00 |
| Vermillion (VRML) | United States | $0.038B | 0.00 |
| ConforMIS (CFMS) | United States | $0.033B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.028B | 0.00 |
| Neovasc (NVCN) | Canada | $0.027B | 0.00 |
| PAVmed (PAVM) | United States | $0.027B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.027B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.022B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.021B | 0.00 |
| Dynatronics (DYNT) | United States | $0.021B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.015B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.015B | 0.00 |
| Presbia (LENS) | Ireland | $0.012B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.010B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.009B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.008B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.007B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.007B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Amedica (SINT) | United States | $0.003B | 0.00 |
| EnteroMedics (RSLS) | United States | $0.000B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
